Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B and T cell prolymphocytic leukaemia
Matthew Cross, Claire Dearden
Best Practice & Research Clinical Haematology (2019) Vol. 32, Iss. 3, pp. 217-228
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The impact of AI and ChatGPT on research reporting
Zubair M. Mojadeddi, Jacob Rosenberg
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 60-64
Open Access | Times Cited: 16
Advances and Perspectives in the Treatment of T-PLL
Till Braun, Jana von Jan, Linus Wahnschaffe, et al.
Current Hematologic Malignancy Reports (2020) Vol. 15, Iss. 2, pp. 113-124
Open Access | Times Cited: 42
T-cell prolymphocytic leukemia, a case report and review of the literature
Luis Manuel GONZáLEZ-RODRíGUEZ, Luis Miguel Juárez‐Salcedo, Javier Loscertales, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2025) Vol. 33, Iss. 3, pp. 505-517
Closed Access
KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
Elena Vendramini, Riccardo Bomben, Federico Pozzo, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 666-666
Open Access | Times Cited: 21
Food security during nuclear winter: a preliminary agricultural sector analysis for Aotearoa New Zealand
Nick Wilson, Marnie Prickett, Matt Boyd
New Zealand medical journal (2023) Vol. 136, Iss. 1574, pp. 65-81
Open Access | Times Cited: 7
Chronic lymphocytic leukaemia/small lymphocytic lymphoma and mantle cell lymphoma: from early lesions to transformation
Birgitta Sander, Elı́as Campo, Eric D. Hsi
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 131-145
Open Access | Times Cited: 11
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
Robert Puckrin, Mona Shafey, Jan Storek
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 6
Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways
Till Braun, Markus Glaß, Linus Wahnschaffe, et al.
Haematologica (2020) Vol. 107, Iss. 1, pp. 187-200
Open Access | Times Cited: 14
Initial treatment of B‐cell prolymphocytic leukemia with ibrutinib
Jeremiah Moore, Andrea Baran, Philip J. Meacham, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 5
Open Access | Times Cited: 10
Inclusion of ethnicity in Special Authority criteria improves access to medications for Māori and Pacific peoples with type 2 diabetes
Ryan Paul, Rāwiri Keenan, Mark Rodrigues, et al.
New Zealand medical journal (2023) Vol. 136, Iss. 1574, pp. 93-97
Open Access | Times Cited: 3
Complement Activation in the Treatment of B-Cell Malignancies
Clive S. Zent, Jonathan J. Pinney, Charles C. Chu, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 68-68
Open Access | Times Cited: 6
Sustained MRD negative remission in del17p and TP53 mutated B cell prolymphocytic leukemia with ibrutinib and venetoclax
Maria Siddiqui, Allyson Price, Alessandra Ferrajoli, et al.
Leukemia Research Reports (2021) Vol. 16, pp. 100266-100266
Open Access | Times Cited: 6
Invasive group A streptococcal disease in Hawke’s Bay, New Zealand: epidemiology, manifestations and impact
Johanna M Birrell, Bridget S. Wilson, Susan Taylor, et al.
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 33-41
Open Access | Times Cited: 2
How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen
José Cabeçadas, Victor E. Nava, João L. Ascensão, et al.
Current Oncology (2021) Vol. 28, Iss. 6, pp. 4611-4633
Open Access | Times Cited: 5
Retrospective analysis of a cohort of 41 <i>de novo</i> B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study)
Caroline Algrin, Louis Pérol, Élise Chapiro, et al.
Haematologica (2022) Vol. 108, Iss. 6, pp. 1691-1696
Open Access | Times Cited: 3
Acute otolaryngological presentations in Northland, New Zealand: analysed with respect to geography and rurality
Subhaschandra Shetty, Chelsea L. Heaven, Matthew McGuinness
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 22-32
Open Access | Times Cited: 1
Psychosocial care in DHB-based stroke services in Aotearoa: a survey of current practice
Felicity Bright, John M. Davison, G Abernathy
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 50-59
Open Access | Times Cited: 1
Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
David B Menkes, Barbara Mintzes, Joel Lexchin
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 7-9
Open Access | Times Cited: 1
Inclusive medical education for students with disabilities: a new guidance document from Medical Deans Australia and New Zealand
Dabrina Issakhany, Peter Crampton
New Zealand medical journal (2023) Vol. 136, Iss. 1575, pp. 65-71
Open Access | Times Cited: 1
Genetic discrimination by insurance companies in Aotearoa New Zealand: experiences and views of health professionals
Harry Fraser, Kimberley Gamet, Sally Jackson, et al.
New Zealand medical journal (2023) Vol. 136, Iss. 1574, pp. 32-52
Open Access | Times Cited: 1
Aotearoa New Zealand emergency ambulance services and the provision of end-of-life care: a short survey
A. Munro, Kate Grundy, Sara Davis
New Zealand medical journal (2023) Vol. 136, Iss. 1574, pp. 15-23
Open Access | Times Cited: 1
Isolation and culture of chicken bone marrow-derived CD34+ hematopoietic stem and progenitor cells and induced differentiation to myeloid cells
Shuhai He, Jing Guo, D. G. Rao, et al.
Tissue and Cell (2023) Vol. 84, pp. 102185-102185
Open Access | Times Cited: 1
An effective treatment and suspicious adverse reaction to Ibrutinib in a patient diagnosed with splenic B-cell lymphoma/leukaemia with prominent nucleoli: A first case report
Meixiao Shen, F. Li, Xian‐Sheng Luo, et al.
Medicine (2023) Vol. 102, Iss. 52, pp. e36022-e36022
Open Access | Times Cited: 1
Identification of microRNA editing sites in three subtypes of leukemia
Wenping Xie, Jun Yang, Nan Zhou, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 2
De novo chronic lymphocytic leukemia/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase
Zachariah Chowdhury, Yookarin Khonglah, Susmita Sarma, et al.
Autopsy and Case Reports (2020) Vol. 11
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top